A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: the HOMAGE trial
Event:
Heart Failure 2023
Topic:
Imaging
Session:
Chronic heart failure - imaging 1